Streetbeat News

Analyst Ratings

FLYX

BTIG analyst Marvin Fong downgraded flyExclusive (AMEX:FLYX) from Buy to Neutral, indicating a change in the stock's outlook.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:25 pm

ADI

AUPH

COTY

CRSP

GKOS

JACK

ROOT

UCTT

WING

WIX

Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including raising and lowering price targets for stocks like Wix.com Ltd. (WIX), Analog Devices, Inc. (ADI), and others. These changes reflect analysts' latest views on these companies, potentially influencing their stock prices in the short term.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 12:23 pm

GTES

Keybanc analyst Jeffrey Hammond has upgraded Gates Industrial Corp (GTES) from Sector Weight to Overweight and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:21 pm

MLM

HSBC analyst Wesley Brooks upgraded Martin Marietta Materials (NYSE:MLM) from Reduce to Hold and increased the price target from $376 to $543, indicating a more positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:18 pm

ROOT

Cantor Fitzgerald analyst Josh Siegler upgrades Root, Inc. (NASDAQ:ROOT) from Neutral to Overweight and increases the price target from $9 to $13.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:14 pm

WIX

Wix.com Ltd. (NASDAQ:WIX) reported Q4 financial results surpassing expectations with a 14% Y/Y revenue increase to $403.8 million and an adjusted EPS of $1.22. The company forecasts Q1 revenue between $415 million to $419 million and fiscal 2024 revenue between $1.73 billion to $1.76 billion. Wix.com shares rose 5.9% following the announcement. Analysts from Piper Sandler and Needham raised their price targets on Wix.com, citing strong performance and future growth prospects.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 12:12 pm

COTY

TD Cowen analyst Oliver Chen upgraded Coty (NYSE:COTY) from Market Perform to Outperform and increased the price target from $13 to $16.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:06 pm

ABCL

Benchmark analyst Robert Wasserman upgrades AbCellera Biologics (NASDAQ:ABCL) from Hold to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:05 pm

UCTT

Needham analyst Charles Shi maintains a Buy rating on Ultra Clean Holdings (UCTT) and raises the price target from $46 to $50.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:02 pm

ALIT

Alight (NYSE:ALIT) received mixed analyst ratings with an updated average 12-month price target of $12.2, reflecting a 7.68% increase from the previous target. The company, specializing in cloud-based human capital solutions, showed a revenue growth of 8.4% as of September 30, 2023, but struggles with profitability and efficiency metrics like net margin, ROE, and ROA. Despite these challenges, its debt management appears sound.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 12:01 pm